My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2025-222
CBCC
>
Official Documents
>
2020's
>
2025
>
2025-222
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
10/27/2025 12:21:30 PM
Creation date
10/27/2025 12:20:45 PM
Metadata
Fields
Template:
Official Documents
Official Document Type
Settlement Agreement
Approved Date
10/07/2025
Control Number
2025-222
Agenda Item Number
9.U.
Entity Name
Purdue
Subject
Participation in New National Opioid Settlement
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
7
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Docusign Envelope ID: C9B35A15-5A87-4F3C-9F35-8C9E5F3BB32B <br />effective. If the Purdue Settlement does not move forward, that release will not <br />become effective. <br />Any subdivision that does not participate in the Purdue Direct Settlement cannot <br />directly share in the Purdue Direct Settlement funds, even if other subdivisions in the <br />state are participating and sharing in those Purdue Direct Settlement funds. Any <br />subdivision that does not participate may also reduce the amount of money for <br />programs to remediate the opioid crisis in its state. Please note, a subdivision will not <br />necessarily directly receive Purdue Settlement funds by participating; decisions on <br />how Purdue Settlement funds will be allocated within a state are subject to intrastate <br />agreements or state statutes. <br />You are encouraged to discuss the terms and benefits of the Purdue Settlement with <br />your counsel, your Attorney General's Office, and other contacts within your state. <br />Many states are implementing and allocating funds for the Purdue Settlement the <br />same as they did for the prior opioids settlements but states may choose to treat the <br />Purdue Settlement differently. <br />Information and documents regarding the Purdue Settlement, including a complete <br />copy of the Governmental Entity and Shareholder Direct Settlement Agreement, and <br />how it is being implemented in your state and how funds will be allocated within your <br />state can be found on the national settlement website at <br />https://nationalopioidsettlement.com/purdue-sacklers-settlements/. This website <br />will be supplemented as additional documents are created. <br />How to return signed forms: <br />There are three methods for returning the executed Participation Form and any <br />supporting documentation to the Implementation Administrator: <br />(1) Electronic Signature via DocuSign: Executing the Participation Form <br />electronically through DocuSign will return the signed form to the <br />Implementation Administrator and associate your form with your subdivision's <br />records. Electronic signature is the most efficient method for returning the <br />Participation Form, allowing for more timely participation and the potential to <br />meet higher settlement payment thresholds, and is therefore strongly <br />encouraged. <br />(2)Manual Signature returned via DocuSign: DocuSign allows forms to be <br />downloaded, signed manually, then uploaded to DocuSign and returned <br />automatically to the Implementation Administrator. Please be sure to complete <br />all fields. As with electronic signature, returning a manually signed <br />Participation Form via DocuSign will associate your signed forms with your <br />subdivision's records. <br />(3)Manual Signature returned via electronic mail: If your subdivision is unable to <br />return an executed Participation Form using DocuSign, the signed Participation <br />Form may be returned via electronic mail to or)ioidsparticipation0rubris.com. <br />
The URL can be used to link to this page
Your browser does not support the video tag.